Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VAC069: P. vivax CHMI Study
NCT03797989Phase 1Completed
- Sponsor
- University of Oxford
- Start
- Jan 2019
- Primary completion
- Dec 2022
- Countries
- 1
01
Overview
Phase 1, open-label trial in malaria (12 arms), sponsored by University of Oxford. Primary endpoints: Number of Participants With Serious Adverse Events at 36 months, Number of Participants Who Developed Infection/Reached Diagnosis Criteria at 3 months and 1 more. Started Jan 2019; status: completed.
02
Conditions
malaria
Beyond the preview
Go deeper on NCT03797989.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03797989.